Breast augmentation is a billion dollar industry, and it now appears that the universal desire amongst women for bigger breasts is set to drive forward stem cell research and its commercial applications.
Stem Cell therapy appears to have limitless applications, from health to cosmetics. But researchers have found that one of the easiest and already successfully tested applications is in breast augmentation.
Trials in breast growth (and re-growth in the case of breast cancer survivors recovering from mastectomies, lumpectomies and quadrantectomies) have been promising. Since the tissues induce the formation of blood vessels, the regenerative cells link the blood supply to the fat cells they’re traveling with, presenting a much lower risk of reabsorption than the injection of fat cells alone. In 2007, a cosmetic surgeon in Japan began a human study and reported that patients injected with the stem-cell-loaded fat solution grew an average of 4 centimeters in breast circumference while the tissue remained soft and natural.
If the San Diego-based biotech company Cytori Therapeutics that developed the centrifuge system gets FDA approval for clinical trials, they could find themselves at the forefront of the regenerative medical industry; but not before they tap in to the sizeable market of women willing to trade surplus fat elsewhere for a more shapely bustline
Source : In Japanese Study, Stem Cell Injections Shown to Provide Simple Route to Breast Augmentation